Overview

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

Status:
Completed
Trial end date:
2017-05-24
Target enrollment:
Participant gender:
Summary
A safety study to compare the effect of two different formulations of PrEP-001 nasal powder when dosed in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Prep Biopharm Limited
Treatments:
Poly I-C